BioAge Labs Inc

BioAge Labs insiders are buying stock options in a coordinated move, signalling confidence in the company’s drug pipeline and potential upside.

BioAge Labs CFO’s bulk purchase signals confidence, potentially easing volatility and boosting investor sentiment amid recent equity raise and clinical milestones.

BioAge Labs CFO buys while execs sell—insider moves show confidence yet liquidity needs. Explore how strategic trades impact the company’s future.